Advertisement|Remove ads.

UnitedHealth Group (UNH) heads into its quarterly earnings report due Tuesday, with investors watching whether recovery at Optum, its healthcare services and care-delivery arm, can begin to offset Medicare payment pressure that erased billions from expected revenue.
UNH stock slipped 0.4% on Monday to end at $323.48, but rose 0.5% in extended trading.
Piper Sandler reiterated an 'Overweight' rating and a $399 price target, implying a 23% upside from current levels ahead of Tuesday’s first-quarter (Q1) results. The brokerage adjusted its expectations for when Optum Health is likely to generate most of its profits this year, but said its updated forecast still aligns with the company’s guidance that nearly two-thirds of 2026 earnings per share should come in the first half of the year.
Piper Sandler expects UNH to post adjusted earnings of about $17.79 per share in 2026, broadly in line with the company’s guidance and close to Wall Street’s estimate of $17.89. This would mark an increase from $16.35 per share in 2025, even as revenue is expected to exceed $439 billion.
The brokerage firm added it would “continue to be buyers of multi-year turnarounds at UnitedHealthcare and Optum Health.”
Separately, Jefferies raised its price target on UnitedHealth shares to $373 from $340 while maintaining a 'Buy' rating, representing a 15% upside from current levels following adjustments to estimates across its managed-care coverage universe.
Despite bullish analyst updates, Medicare Advantage reimbursement changes remain the primary driver of UnitedHealth’s earnings recovery. Risk-adjustment revisions introduced over the past several years have already removed billions of dollars from expected revenue and are estimated to have a $6 billion remaining impact into 2026, Bloomberg noted.
The company’s exposure is especially significant as UnitedHealth serves over 8 million Medicare Advantage members, the largest footprint in the industry, making payment revisions noteworthy for its earnings outlook.
Much of the bull case for UNH stock now depends on the performance of Optum Health, historically one of the company’s biggest drivers of profit growth before changes to Medicare Advantage risk-adjustment payment formulas last year reduced expected reimbursements and pushed the unit into a loss.
The company responded by scaling back higher-risk care arrangements and exiting Medicare Advantage plans in 109 counties, affecting 180,000 members. In January, the insurer said during its earnings call that the unit entered 2026 on a “stronger foundation” after reducing its exposure to underperforming risk-based contracts.
Investor sentiment toward UNH shares came under fresh pressure earlier this year after regulators initially proposed a near-flat 0.09% Medicare Advantage payment increase for 2027, triggering a sector-wide selloff that erased $60 billion in market value in a single session. Final reimbursement updates later improved to 2.48%, helping stabilize sentiment across insurers.
On Stocktwits, retail sentiment for UNH jumped to ‘bullish’ from ‘neutral’ levels a day ago amid over a 1,150% surge in 24-hour message volumes.

One user said, “The fact that today was not green is actually overall positive for tomorrow to have a nice pop up again on guidance. Guidance will be far more important than numbers tomorrow. I’m thinking $400+ by August “
Another user said, “ER shouldn’t stress longs. Just another dividend payment processed. UNH will be back stronger then ever before. Maybe not tomorrow, but longs will have the last laugh here.”
UNH stock has declined 27% over the past year.
For updates and corrections, email newsroom[at]stocktwits[dot]com.
Read Next: Tesla Stock Slides As Q1 Earnings Loom: One Wall Street Analyst Still Sees 10% More Downside